Wolverine Trading, LLC Seagen Inc. Put Options Transaction History

Wolverine Trading, LLC

11 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2023 Nov 15, 2023	SELL	$191.51 - $216.16 $114,906 - $129,696	-600 Reduced 14.63%	3,500 $742,000
Q2 2023 Aug 23, 2023	SELL	$187.64 - $206.25 $487,863 - $536,250	-2,600 Reduced 38.81%	4,100 $789,000
Q1 2023 May 15, 2023	BUY	$127.59 - $203.08 $472,083 - $751,396	3,700 Added 123.33%	6,700 $1.36 Million
Q4 2022 Feb 14, 2023	SELL	$117.37 - $139.17 $1.4 Million - $1.66 Million	-11,900 Reduced 79.87%	3,000 $386,000
Q3 2022 Nov 14, 2022	BUY	$135.27 - $180.11 $1.53 Million - $2.04 Million	11,300 Added 313.89%	14,900 $2.02 Million
Q2 2022 Aug 15, 2022	SELL	$108.81 - $179.33 $533,169 - $878,717	-4,900 Reduced 57.65%	3,600 $645,000
Q4 2021 Feb 14, 2022	SELL	$142.57 - $190.86 $213,855 - $286,290	-1,500 Reduced 15.0%	8,500 $1.34 Million
Q3 2021 Nov 12, 2021	BUY	$142.45 - $169.82 $512,819 - $611,352	3,600 Added 56.25%	10,000 $1.64 Million
Q2 2021 Aug 06, 2021	SELL	$135.08 - $161.1 $310,684 - $370,530	-2,300 Reduced 26.44%	6,400 $1.02 Million
Q1 2021 May 14, 2021	SELL	$137.51 - $190.8 $756,305 - $1.05 Million	-5,500 Reduced 38.73%	8,700 $1.2 Million
Q4 2020 Feb 12, 2021	BUY	$164.63 - $211.93 $2.34 Million - $3.01 Million	14,200 New	14,200 $2.61 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.